Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 25 most recent Form 4 transactions.
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 47,667 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 60,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 126,667 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 157,500 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 157,500 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 125,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 375,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 440,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 506,250 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 70,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 47,667 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 60,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 126,667 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 157,500 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 157,500 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 125,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 375,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 440,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 506,250 | — | — | — | Open the original filing on SEC.gov |
| Jan 30 | HRTX | Heron Therapeutics, INC.… | AGRANT | 53,960 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 506,250 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | GOSS | Gossamer Bio, Inc. | AGRANT | 84,500 | — | — | +11.6% | Open the original filing on SEC.gov |
| Oct 1, 2025 | GOSS | Gossamer Bio, Inc. | AGRANT | 125,000 | — | — | +21.3% | Open the original filing on SEC.gov |